Blood Transfusion Market: Information by Product (Blood Bag and Accessory, and Consumables and Supplies), End-User (Hospitals and Ambulatory Surgical Centers), and Region—Forecast till 2029

Request Free Sample Report

Table Of Content

1          Introduction

1.1       Market Definition

1.2       Market Scope

2          Research Methodology

2.1       Primary Research

2.2       Research Methodology

2.3       Assumptions & Exclusions

2.4       Secondary Data Sources

3          Market Overview

3.1       Report Segmentation & Scope

3.2       Value Chain Analysis: Blood Transfusion Market

3.3       Key Market Trends

3.3.1   Drivers

3.3.2   Restraints

3.3.3   Opportunities

3.4       Porter’s Five Forces Analysis

3.4.1   Bargaining Power of Suppliers

3.4.2   Bargaining Power of Buyers

3.4.3   Threat of Substitution

3.4.4   Threat of New Entrants

3.4.5   Competitive Rivalry

3.5       Market Share Analysis

3.6       Top Winning Strategies

3.7       Top Investment Pockets

3.8       Impact of COVID-19 on Blood Transfusion Market Overview

4          Product Overview

4.1       Blood Bag and Accessory

4.1.1   Market Size & Forecast (Value)

4.2       Blood Mixer

4.2.1   Market Size & Forecast (Value)

4.3       Blood Component Separator

4.3.1   Market Size & Forecast (Value)

4.4       Apheresis Device

4.4.1   Market Size & Forecast (Value)

4.5       Pathogen Reduction System

4.5.1   Market Size & Forecast (Value)

4.6       Consumables and Supplies

4.6.1   Market Size & Forecast (Value)

4.7       Others

4.7.1   Market Size & Forecast (Value)

5          End-User Overview

5.1       Hospitals

5.1.1   Market Size & Forecast (Value)

5.2       Blood Banks

5.2.1   Market Size & Forecast (Value)

5.3       Ambulatory Surgical Centres

5.3.1   Market Size & Forecast (Value)

5.4       Others

5.4.1   Market Size & Forecast (Value)

6          Region Overview

6.1       Introduction

6.1.1   Market Size & Forecast (Value)

6.2       Americas

6.2.1   North America

6.2.1.1            The U.S.

6.2.1.1.1         By Product

6.2.1.1.2         By End-User

6.2.1.2            Canada

6.2.1.2.1         By Product

6.2.1.2.2         By End-User

6.2.2   Central and South America and the Caribbean

6.2.2.1            By Product

6.2.2.2            By End-User

6.3      Europe

6.3.1   Market Size & Forecast (Value)

6.3.2   Western Europe

6.3.2.1            The U.K.

6.3.2.1.1         By Product

6.3.2.1.2         By End-User

6.3.2.2            Germany

6.3.2.2.1         By Product

6.3.2.2.2         By End-User

6.3.2.3            France

6.3.2.3.1         By Product

6.3.2.3.2         By End-User

6.3.2.4            Spain

6.3.2.4.1         By Product

6.3.2.4.2         By End-User

6.3.2.5            Italy

6.3.2.5.1         By Product

6.3.2.5.2         By End-User

6.3.2.6            The Rest of Western Europe

6.3.2.6.1         By Product

6.3.2.6.2         By End-User

6.3.3   Eastern Europe

6.3.3.1            By Product

6.3.3.2            By End-User

6.3.4   Rest of Europe (ROE)

6.3.4.1            By Product

6.3.4.2            By End-User

6.4      Asia-Pacific

6.4.1   Market Size & Forecast (Value)

6.4.1.1            Japan

6.4.1.1.1         By Product

6.4.1.1.2         By End-User

6.4.1.2            China

6.4.1.2.1         By Product

6.4.1.2.2         By End-User

6.4.1.3            Australia

6.4.1.3.1         By Product

6.4.1.3.2         By End-User

6.4.1.4            India

6.4.1.4.1         By Product

6.4.1.4.2         By End-User

6.4.1.5            South Korea

6.4.1.5.1         By Product

6.4.1.5.2         By End-User

6.4.1.6            The Rest of Asia-Pacific (Ro APAC)

6.4.1.6.1         By Product

6.4.1.6.2         By End-User

6.5      The Middle East & Africa

6.5.1   The Middle East & Africa

6.5.1.1            By Product

6.5.1.2            By End-User

7          Company Profiles    

7.1      Grifols S.A. (Spain)

7.1.1   Company Overview

7.1.2   Financial Performance

7.1.3   Recent Developments

7.1.4   Product Portfolio

7.2      Immucor Inc. (US)

7.2.1   Company Overview

7.2.2   Financial Performance

7.2.3   Recent Developments

7.2.4   Product Portfolio

7.3      Ortho Clinical Diagnostics (US)

7.3.1   Company Overview

7.3.2   Financial Performance

7.3.3   Recent Developments

7.3.4   Product Portfolio

7.4      Abbott Laboratories (US)

7.4.1   Company Overview

7.4.2   Financial Performance

7.4.3   Recent Developments

7.4.4   Product Portfolio

7.5      Bio-Rad Laboratories, Inc. (US)

7.5.1   Company Overview

7.5.2   Financial Performance

7.5.3   Recent Developments

7.5.4   Product Portfolio

7.6      F. Hoffmann-La Roche Ltd. (Switzerland)

7.6.1   Company Overview

7.6.2   Financial Performance

7.6.3   Recent Developments

7.6.4   Product Portfolio

7.7      Quotient Ltd. (Switzerland)

7.7.1   Company Overview

7.7.2   Financial Performance

7.7.3   Recent Developments

7.7.4   Product Portfolio

7.8      BD (US)

7.8.1   Company Overview

7.8.2   Financial Performance

7.8.3   Recent Developments

7.8.4   Product Portfolio

7.9      Terumo Corporation (Japan)

7.9.1   Company Overview

7.9.2   Financial Performance

7.9.3   Recent Developments

7.9.4   Product Portfolio

7.10    B. Braun (Germany)

7.10.1 Company Overview

7.10.2 Financial Performance

7.10.3 Recent Developments

7.10.4 Product Portfolio

9          Conclusion & Recommendations

10        Acronyms & Abbreviations

 

Report Description Download Sample

Copyright . All rights Reserved By Straits Research